UBS raised the firm’s price target on Aptiv (APTV) to $99 from $94 and keeps a Neutral rating on the shares. The firm is relatively cautious heading into earnings, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTV:
- Aptiv upgraded to Outperform from Equal-Weight at Fox Advisors
- Aptiv upgraded to Overweight from Neutral at Piper Sandler
- Aptiv Re-Rated to Buy: Hardware Strength, Spin-Off Catalyst, and SOTP Valuation Underscore Upside to $103 Target
- Aptiv, Vecna enter strategic collaboration to develop autonomous mobile robots
- Aptiv upgraded to Equal Weight from Underweight at Morgan Stanley